Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA; email:
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:583-601. doi: 10.1146/annurev-pharmtox-010617-052844. Epub 2017 Oct 6.
Over 70% of Americans take some form of dietary supplement every day, and the supplement industry is currently big business, with a gross of over $28 billion. However, unlike either foods or drugs, supplements do not need to be registered or approved by the US Food and Drug Administration (FDA) prior to production or sales. Under the Dietary Supplement Health and Education Act of 1994, the FDA is restricted to adverse report monitoring postmarketing. Despite widespread consumption, there is limited evidence of health benefits related to nutraceutical or supplement use in well-nourished adults. In contrast, a small number of these products have the potential to produce significant toxicity. In addition, patients often do not disclose supplement use to their physicians. Therefore, the risk of adverse drug-supplement interactions is significant. An overview of the major supplement and nutraceutical classes is presented here, together with known toxic effects and the potential for drug interactions.
超过 70%的美国人每天都会服用某种形式的膳食补充剂,而补充剂行业目前是一个大产业,总销售额超过 280 亿美元。然而,与食品或药物不同,补充剂在生产或销售之前不需要经过美国食品和药物管理局(FDA)的注册或批准。根据 1994 年的《膳食补充剂健康与教育法案》,FDA 只能在上市后进行不良反应报告监测。尽管补充剂被广泛消费,但在营养良好的成年人中,与营养保健品或补充剂使用相关的健康益处的证据有限。相比之下,这些产品中有一小部分具有产生显著毒性的潜力。此外,患者通常不会向医生透露补充剂的使用情况。因此,药物-补充剂相互作用的风险是显著的。这里介绍了主要的补充剂和营养保健品类别,以及已知的毒性作用和药物相互作用的可能性。